Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

AffaMed Therapeutics

Request full access

Biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs in ophthalmology, and neurological and psychiatric…

Huangpu, ChinaFounded 2019Biotech & Life Sciences

At a glance

Status
Operational
Employees
32
Open positions
None listed
Dealroom signal
32.8/100
Industry
Health
Sub-industry
Pharmaceutical, BioTechnology
Sector
Biotechnology, Rumoured $1B, Biotech and Pharma, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

1 recorded event

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES BOther financing Mar 2021 $170M $680M Lake Bleu Capital · CBC Group · Partners Investment · Fountainhead Investment Partners —
Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Growth signals

AffaMed Therapeutics website traffic

Latest recorded traffic for AffaMed Therapeutics is 2.1K monthly website visits, up 75% over the last three months. AffaMed Therapeutics's team declined 30.4% over the past year.

Latest monthly visits2.1K 3-month web change+75% 1-year team growth-30.4%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

AffaMed Therapeutics in the Huangpu ecosystem

Live from Dealroom

The AffaMed Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

6 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A6 investors entered at this stage

  • Lake Bleu Capital
  • CBC Group
  • Partners Investment
  • Fountainhead Investment Partners
  • Superstring Capital
  • Orion Science Capital
Team profiled 1 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
4 countries with
team presence
🇨🇳 China78.3%
🇺🇸 United States13%
🇸🇬 Singapore4.3%
🇭🇰 Hong Kong4.3%
4 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about AffaMed Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See AffaMed Therapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.